Literature DB >> 34106650

Using decision trees to determine participation in bundled payments in sepsis cases.

William Matzner1, Deborah Freund2.   

Abstract

RATIONALE: The purpose of this research is to determine and develop a valid analytical method that can be easily implemented by providers to evaluate whether they should join the bundled payments for care improvement (BPCI) advanced bundled payment program, and analyze the projected impacts of BPCI advanced payment on their margins.
METHODS: We have developed a decision tree model that incorporates the types of sepsis encountered and the resultant typical complications and associated costs.
RESULTS: The initial cost of a sepsis episode was $30,386. Since Medicare requires that there is a 3% cost reduction under BPCI, we applied the model with a 3% cost reduction across the board. Since the model considers probabilities of the complications and readmission, there was actually a 3.36% reduction in costs when the 3% reduction was added to the model. We applied 2-way sensitivity analysis to the intensive care unit (ICU) long and short costs. We used the unbundled cost at the high end, and a 10% reduction at the low end. Per patient episode cost varied between $28,117 and $29,658. This is a 5.2% difference between low and high end. Next, we looked at varying the hospital bed (non-ICU) costs. Here the resultant cost varied between $28,708 and $29,099. This is only a 1.34% difference between low and high ends. Finally, we applied a sensitivity analysis varying the attending physician and the intensivist reimbursement fees. The result was a cost that varied between $29,191 and $29,366 which is a difference of only 0.595%.
CONCLUSION: This is the precise environment where decision tree analysis modeling is essential. This analysis can guide the hospital in just how to allocate resources in light of the new BPCI advanced payment model.
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

Entities:  

Year:  2021        PMID: 34106650      PMCID: PMC8133040          DOI: 10.1097/MD.0000000000025902

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


Introduction

The cost of healthcare continues to increase with new developments in pharmacology, technology, precision medicine, higher provider fees, and a society living actively longer than ever before. This has led Center for Medicare and Medicaid Services (CMS), that runs Medicare and Medicaid as well as private insurers to develop alternate payment approaches to address the perceived weakness of the fee-for-service method. One of the new methods is bundled payments meant to bring about lower costs and higher quality by omitting fee-for-service payments which are seen as incentivizing “unnecessary” treatment without any improvement in quality. Capitation (in which providers are given a defined sum per patient regardless of how many services are rendered in a given period of time) has been used for many years in both health maintenance organization (HMOs) and Medicare Advantage plans, also known as Medicare Part C. The Center for Medicare and Medicaid Innovation (CMMI) which is part of CMS has developed a hybrid that is in-between full capitation and fee for service called bundled payments or episode-based payments.[ In this system, reimbursements to healthcare providers (both hospitals and physicians) are made on the basis of a calculated expected cost formula for clinically defined episodes of care. As of 2012 almost one-third of medical reimbursement are now from a bundling system.[ The bane of capitation both in integrated delivery models and in HMOs has been the extent and thoroughness of patient care possible through episodes of care that involve different providers with sometimes different patient management objectives. As a result, the purpose of this research is to determine and develop a valid analytical method that can be easily implemented by providers to evaluate whether they should join the newest bundled payment program now, bundled payments for care improvement (BPCI) advanced, and analyze the projected impacts of BPCI advanced payment on their margins. Based upon the specific inputs in the model, a hospital can determine if joining BPCI advanced is a profitable idea or not, so as to make a more informed decision when choosing whether or not to participate. Such a method should be able to consider the variables/treatments all providers who treat a specific condition use in treating patients with complex disorders.

Background

Bundling payments were first introduced by Dr Denton Cooley in 1984 at the Texas Heart Institute (THI). Dr Cooley charged a flat fee for combined hospital and physician services for coronary artery bypass grafts. THI charged an average of $13,800, when the average Medicare payment for coronary artery bypass graft (CABG) was over $24,500.[ In 2006 the Geisinger Health System tested another bundling model, also for coronary artery bypass surgery.[ This model included all preoperative, in-patient and operative care and follow up care within 90 days of the initial visit, at a fixed package price. This experiment resulted in shorter hospital stays, a 5% reduction in hospital costs, an increased chance of being discharged directly to home rather than sent to a skilled nursing facility (SNF), and a decrease in readmission rates.

Current environment

In 2012, Medicare introduced BPCI program as a result of the Affordable Care Act.[ Participants, in this voluntary program, could choose 1 of 4 payment models for 48 possible clinical episodes. Most participants opted for Model 2 which included an inpatient stay plus outpatient follow up for a period of 30, 60, or 90 days. Payments were reconciled comparing actual Medicare Payments to a payment target set by Medicare based on previous payments for similar cases. Spending generally trended lower, and in the case of hip/knee replacement there was an estimated savings of $1273 per episode, which came mostly from a reduction in SNF use in the postoperative period. In 2016, CMMI introduced a mandatory bundled payment program for hip and knee replacement called the comprehensive joint replacement model (CJR).[ This experimental program involving 800 hospitals resulted in a savings of $1134 per episode. In 2018, CMMI Medicare also introduced a variation called bundled payment for care improvement advanced (BPCI advanced).[ This voluntary Medicare program was designed as an alternative to the traditional fee for service payment model. In theory it was designed to support healthcare providers who invest in practice innovation and care redesign to better coordinate care and expenditures. It involves paying the physician, hospital, and other healthcare services in one single payment that is based on the expected costs during an episode of care. The incentive is for providers and suppliers to coordinate and deliver care with increased quality and less cost. There are several differences between the original BPCI and the new BPCI advanced programs.[ First, all participants will be responsible for 90-day bundles. In the original BPCI, there was an option to choose 30, 60, or 90-day bundles. Next, there are fewer exclusions, so that the bundle includes all part A services, including the hospital stay, hospital procedures, and post-acute care services, plus all part B outpatient services unless they are not related at all to the admission diagnosis related group (DRG). Furthermore, up to 10% of payments are at risk for quality measures. There is also only a single track for treatment of outliers. And reconciliation reports will only be sent to participants bi-annually. This new iteration of BPCI is voluntary and involves a single retrospective payment for a 90-day clinical episode. This has been designed by CMS. There are 31 inpatient and 4 outpatient clinical episodes included. Payment is tied to performance on certain quality measures defined by CMS. For BPCI Advanced, 4 payment models were available, with Model 2 being the most common.[ All payment bundles are fixed to a 90-day episode, up to 10% of payments in the bundle are at risk based upon certain quality measurements, and there is only a single track of downside financial risk, effective immediately. With downside risk, failure to improve quality or decrease costs (bills to Medicare) leads to hospitals having to return money to Medicare. Studies of the joint replacement bundles have shown no decrease in quality and a small decrease in expenditures.[ However, there are several limitations to using joint replacement as a template for how bundling will work for different episodes. Notably, joint replacement, an elective surgery, is a standard and defined procedure. The surgery is virtually the same for each patient. Since joint replacement is an elective procedure, it can be assumed that all patients undergoing the surgery have been screened to reduce the risk of perioperative cardiovascular or pulmonary complications. In fact, studies show that most all of the cost savings for bundles of hip and knee replacement result from patients going home after being discharged for rehabilitation after discharge from the hospital or outpatient surgery center instead of to a SNF. This is not possible for many of the other medical episodes included in BPCI Advanced. For example, other episodes included in BPCI Advanced are congestive heart failure, chronic obstructive pulmonary disease, sepsis, acute myocardial infarction, and pneumonia. There is a wide variation in the degree of illness and the course of therapy with these diagnoses, and there is no uniformity in treatment guidelines for these diseases. For example, Sepsis includes 3 DRGs which range from uncomplicated sepsis to septic shock. Unlike elective surgery such as hip and knee replacements, patients cannot be screened to avoid complications. In fact, many sepsis patients develop complications and/or have significant comorbidities resulting in extreme variation in length of stay (LOS) and unpredictable costs associated with each hospitalization. Most cases would likely not to need to go to SNF after discharge from a hospital but would most likely need home health care and close medical follow up to avoid readmission.[ Within the joint replacement modeling, the decision of whether a provider should participate is generally simple to calculate. However, in cases where there is a wide variation in cost factors, a model able to address numerous variables attributable to different patients is imperative for a provider to make any informed decision about whether to participate in BPCI Advanced. Our tested and recommended model for these calculations is a Decision Tree Model. Decision tree models offer both the flexibility and complexity of interaction to more accurately predict costs than just a linear model which is commonly used. Since sepsis is a complicated disease that can lead to many possible outcomes that would affect costs, this type of modeling lends itself to such an analysis. Previous studies of cost analysis on BPCI have only compared total costs to what has been predicted. Meyer[ found that bundled payments cut spending on joint replacement but not for other conditions. Agarwal et al[ looked at the impact of bundled payment on healthcare spending utilization, and quality and came to a similar conclusion. The Rand Corporation[ found costs went down only 5% compared with 15% predicted. All such studies look at total cost but did not incorporate different clinical outcomes. We have developed a decision tree model that incorporates the various types of sepsis that are encountered and the resultant typical complications and their associated costs. Sepsis affects 1.7 million adults in the United States each year and potentially contributes to 250,000 deaths. It is present in 34% to 53% of hospitalizations in which the patients died.[ Sepsis is an overwhelming bacterial infection in the body. Bacteria are present within the bloodstream and can lead to organ damage, especially to the kidneys and lungs, and the vascular system. This can become septic shock, which has risen by 10% in the last 3 years. These patients are intubated in the intensive care unit due to respiratory failure, are on dialysis for acute renal failure, and on vasopressor medication to keep their blood pressures high enough to perfuse their brains. Only with the aggressive use of IV antibiotics, IV fluids, and other supportive care will the patient even survive. Reported mortality rates vary between 37% and 45%. Hospital charges are now up from $58,000 to $70,000 per case (although actual costs are less).[ Overall, hospitals spent $1.5 billion more in 2018 on sepsis than in 2015.[

Methods

The decision tree model was developed in Tree Age Pro Version 19.2.1. We constructed 2 branches, 1 for bundled payments, and 1 for non-bundled payments. Figure 1 shows the entire decision tree.
Figure 1

Decision tree model. The decision tree illustrates with this range of variables utilized that bundling is less expensive, at the rate of 3%.

Decision tree model. The decision tree illustrates with this range of variables utilized that bundling is less expensive, at the rate of 3%. There was no need for an ethics committee as we used no individual patient data for the research and did not offer any type of treatment in this study. The possible complications which are analyzed in the model include: acute renal failure, respiratory failure, hypotension, and readmission for sepsis within 1 month of the first admission. However, based on past experience, on a provider-by-provider basis, other complications can be included. Both the number of complications and the specific complications are virtually unlimited and may be customized to reflect the actual use of an individual provider organization or groups of organizations. In this decision tree model there are different “branches” for the different treatment variations, and each branch has an associated cost and probability of occurrence. In the case of the sepsis model for BPCI, there are 2 main branches, 1 for the bundled payment plan (BPCI) and 1 for the unbundled, traditional fee for service payment plan. The branches are identical except for the costs of the different branches. Sepsis has 3 major branches: systemic inflammatory response syndrome (SIRS), sepsis (with complications but not septic shock), and septic shock. The major complications include acute renal failure, hypotension (low blood pressure) that needs pharmacologic support by medications called vasoconstrictors, and septic shock where the patient is in respiratory failure and is intubated. Costs for these complications include the cost of the ICU, the ventilator, dialysis for renal failure, and cost and administration of the vasoconstrictors. These costs were derived from the medical literature and are the average national costs of ventilator, and dialysis management.[ The cost of vasoconstrictors came from the pharmaceutical company that manufactures it.[ Furthermore, the cost per day of the ICU and subsequent regular floor beds are added to the cost. We got these costs from the CFOs of community/hospitals in the California Hospital Association. These costs therefore are illustrative how the model works, but as costs for ICU and regular floor beds may vary across the country, one may not be able to necessarily rely on the specific conclusions of this manuscript. However, if a hospital includes their own values, the model will give an accurate representation of the expected values for their facility. This cost was the per day cost to stay in either an ICU bed or a regular floor bed. We used the average length of stay from the literature in the ICU and subsequent regular floor bed for septic shock, sepsis with complications, and simple sepsis. Finally, we added the daily cost of the physicians involved in the care of each patient. We assumed that the hospital will reimburse the physician at the Medicare payment rate. This rate was derived from the Medicare reimbursement for physicians for their particular level of service. One of the branches of the model is devoted to readmission within the 90-day period prescribed by Medicare BPCI. Therefore, there are 4 branches for the main possible outcomes: SIRS, sepsis (with complications), septic shock, and readmission for sepsis. For both bundled and unbundled, the probabilities are identical—it is only the costs that vary. The probability of SIRS is 26%, sepsis (with complications) is 24%, septic shock is 32%, and the probability of readmission is 29.2%.[ Essentially, there is an expected value calculated (probability times the cost) for each branch, and the expected values of costs are then summed to determine the cost of each branch. The cost of a sepsis admission is the sum of the expected values of all the branches for a particular arm of the model. Data on hospital costs (cost per day in ICU or regular floor bed) were given to us by hospitals that are members of the California Hospital Association. While these data are not representative they are not meant to be. We use them only to illustrate the methods of using decision trees. A similar analysis can be conducted for private patients as well. The payment of physicians was derived from the Medicare Fee Schedule for physicians for the appropriate current procedural termino (CPT) codes. Costs of dialysis and ventilation were derived from the literature. Costs of vasopressors were taken from the drug manufacturer information on their website. The Payoffs for the decision tree, including all costs and probabilities, are listed in Table 1.
Table 1

Payoffs.

NameDescriptionRoot definition
cARFCost of acute renal failure5253
cICU_longCost of long ICU stay20,933
cICU_shortCost of short LOS in ICU7809
cIntensivist_LongCost of intensivist in ICU long stay2164
cIntensivist_ShortCost of intensivist in ICU short stay777
cLOS_LongCost of LOS long14,987
cLOS_MediumCost of LOS for medium case4995
cLOS_simpleCost of LOS simple sepsis1654
cMedical_LongCost of medical doctor long stay3310
cMedical_ShortCost of medical doctor short stay2380
cMedical_SimpleCost of medical doctor SIRS823
cNephrologyCost of nephrologist3196
cPressorsCost of pressors2718
cPulmonaryCost of pulmonologist3196
cUICU_shortCost of short LOS in ICU-unbundled8043
cUnARFCost of acute renal failure unbundled5415
cUnICU_longCost of unbundled ICU long21,574
cUnICU_shortCost of unbundled ICU short8050
CUnIntensivist_LongCost of intensivist in ICU long stay unbundled2231
cUnIntensivist_ShortCost of intensivist in ICU short stay unbundled801
cUnLOS_LongCost of unbundled LOS long15,450
cUnLOS_MediumCost of unbundled LOS medium5150
cUnLOS_simpleCost of unbundled LOS simple2060
CUnMedical_LongCost of medical doctor long stay unbundled3412
cUnMedical_ShortCost of medical doctor short stay unbundled2454
cUnMedical_SimpleCost of medical doctor SIRS unbundled848
cUnNephrologyCost of nephrologist unbundled3295
cUnPressorCost of pressors unbundled2802.5
cUnPressorsCost of pressors unbundled2802.5
cUnPulmonaryCost of pulmonologist unbundled3295
cUnVentilationCost of ventilating patient unbundled14,450
cVentilationCost of ventilating patient14,017
effModSepsisEffectiveness of septic shock1.0
effSepsisEffectiveness of simple sepsis1.0
effSepticShockEffectiveness of septic shock1.0
pARFProbability of ARF0.45
pARF_PressorsProbability of ARF and pressors during hospital0.15
pARF_Pressors_REProbability of ARF and pressors during hospital-readmit0.11
pARF_REProbability of acute renal failure readmit0.32
pPressorsProbability of use of pressors in complicated sepsis0.29
pPressors_REProbability of use of pressors in complicated sepsis-readmit0.21
pReadmissionComplicProbability of readmission complication0.292
pReadmissionShockProbability of readmission septic shock0.292
pSepsisProbability of SIRS0.26
pSepsis_Comp_CourseProbability that SIRS becomes complicated0.24
pSepsis_ComplicProbability of complicated sepsis0.25
pSepsis_CourseProbability of SIRS0.75
pSeptic_ShockProbability of septic shock0.32
pVentilProbability of ventilation alone septic shock0.26
pVentil_ARFProbability of ventilator and ARF in septic shock0.25
pVentil_ARF_REProbability of ventilator plus acute renal failure0.18
pVentil_PressorsProbability ventilation and pressors in septic shock0.29
pVentil_Pressors_ARFProbability of pressors and ARF and ventilation in septic shock0.14
pVentil_Pressors_ARF_REProbability of pressors and ventilator and ARF in septic shock-readmit0.10
pVentil_Pressors_REProbability of ventilator and pressors in septic shock-readmit0.21
pVentil_REProbability of ventilation alone septic shock-readmit0.18
Payoffs. For this study, the expected value (EV) of each branch (probability times cost) was calculated, then the EV of all branches summed to get total cost. Two-way sensitivity analysis was also calculated using the software to explore the effects of changing various costs upon the overall model.

Results

We used the model to realistically analyze the effects of varying certain costs on the overall cost to the hospital of a sepsis admission. In that way, hospitals can determine whether likely revenue from bundled payments will be large enough to allow them to both provide care more efficiently and also take on the risk and be rewarded by a share in the savings. The decision tree takes into account 3 major complications: acute renal failure, hypotension, and septic shock with respiratory failure. It also considers the 30-day readmission rate for sepsis, which is quite high. Costs included in the model are short (3.5 days) and long (9.5 days) ICU stay, short (5.1 days) and long (15.4 days) length of stay in a regular room, dialysis costs, respirator costs, medication costs (specifically vasopressors), and costs of the attending physician, intensivist, pulmonologist, and nephrologist. The results are summarized in Table 2. The initial cost of a sepsis episode was $30,386. Since Medicare requires that there is a 3% cost reduction under BPCI, we applied the model with a 3% cost reduction across the board. Since the model considers probabilities of the complications and readmission, there was actually a 3.36% reduction in costs when the 3% reduction was added to the model.
Table 2

Illustrates both the ranges between high and low costs aggregated from among participating hospitals, but also the percent differential.

ParameterLowHighPCT Diff
Baseline$ 29,366$ 30,3863.36
ICU$ 28,117$ 29,6585.2
Hosp Bed$ 28,708$ 29,0991.34
Physician$ 29,191$ 29,3660.595

As is shown, it is the ICU cost that carries the greatest variances and therefore the greatest opportunity for cost management. The least volatile is the physician charge.

Low: 10% below bundled cost.

High: Unbundled cost.

Bundled = 97% unbundled (BPCI requiring 3% cost savings).

ICU = ICU long and short stay.

Hosp Bed = regular bed LOS cost.

Physician = cost of internist and hospitalist.

Illustrates both the ranges between high and low costs aggregated from among participating hospitals, but also the percent differential. As is shown, it is the ICU cost that carries the greatest variances and therefore the greatest opportunity for cost management. The least volatile is the physician charge. Low: 10% below bundled cost. High: Unbundled cost. Bundled = 97% unbundled (BPCI requiring 3% cost savings). ICU = ICU long and short stay. Hosp Bed = regular bed LOS cost. Physician = cost of internist and hospitalist. We next applied 2-way sensitivity analysis to the model and monitored how this affected the model. The purpose of this analysis is to evaluate how either a change in therapy, or a change in costs administratively, can optimize the revenue hospitals and physicians receive under the bundled payment system. Since total revenue is fixed under bundled payments, it is important to minimize costs either by changes in the therapeutic regimen, or a change in costs for a particular episode of care. When deciding what may need to change, it is imperative that one knows what would have the largest impact for a particular change in therapy or cost. This is where sensitivity analysis in a cost effectiveness model can provide insight into what aspect of the care episode needs to be examined more closely. First, we applied the analysis to the ICU long and short costs. We used the unbundled cost at the high end, and a 10% reduction at the low end. The result was that the per patient episode cost varied between $28,117 and $29,658. This is a 5.2% difference between low and high end. Next, we looked at varying the hospital bed (non-ICU) costs. Again, we used the unbundled cost at the high end and a 10% reduction at the low end. Here the resultant cost varied between $28,708 and $29,099. This is only a 1.34% difference between the low and high ends. Finally, we applied a sensitivity analysis varying the attending physician and the intensivist reimbursement fees. The result was a resultant cost that varied between $29,191 and $29,366 which is a difference of only 0.595%.

How to use this analysis

This analysis can guide the hospital in just how to allocate resources in light of the new BPCI advanced payment model. Since revenue is essentially fixed and predetermined, it is imperative that the hospital analyze and then cut back unnecessary costs while still maintaining excellent delivery of healthcare to the sepsis patient. Our analysis shows that the biggest impact would be to cut back on the length of ICU care, and/or to cut some of the costs that are incurred in the ICU. One can see that a combination of savings through medical methodology plus administrative efficiency can lead to a savings of $3873 per admission. See Table 3. Since revenue is fixed, this would go straight to profit. If using the same example of a hospital with 25 ICU beds, based on the available data it would save $2,649,132 during the course of year which would go to profit under a fixed revenue model such as BPCI advanced.
Table 3

Illustrates the practical application of the modeling to project cost savings in the ICE, the major charge/cost component, when adjusted for individual hospitals.

No. of ICU bedsICU bed days% SepsisSepsis Bd/dAvg LOSCalculated admissionsSavings per admissionTotal annual savings
25912545%41066.0684$ 3873$ 2,649,132

Calculations for Table 3: Enter actual number of ICU Beds, Bed Day calculated as ICU beds times 365, percent sepsis based on reference data averages, Sepsis bed days calculated as percent sepsis times ICU bed days. Calculated sepsis admissions, based on sepsis bed days divided by average sepsis LOS, from reference material, savings per admission is calculated sepsis admissions times the difference between Low and High ICU costs from Table 2 above. Total annual savings is the savings per admission times the calculated sepsis admissions. ICU = intensive care unit, LOS = length of stay.

Illustrates the practical application of the modeling to project cost savings in the ICE, the major charge/cost component, when adjusted for individual hospitals. Calculations for Table 3: Enter actual number of ICU Beds, Bed Day calculated as ICU beds times 365, percent sepsis based on reference data averages, Sepsis bed days calculated as percent sepsis times ICU bed days. Calculated sepsis admissions, based on sepsis bed days divided by average sepsis LOS, from reference material, savings per admission is calculated sepsis admissions times the difference between Low and High ICU costs from Table 2 above. Total annual savings is the savings per admission times the calculated sepsis admissions. ICU = intensive care unit, LOS = length of stay.

Discussion

Bundling payments versus the traditional fee-for-service (FFS) presents a different paradigm in not only how to treat the patients and communicate with specialists, but also how hospitals and hospital administrators and physicians can undertake a different approach to revenue generation in light of the costs that are experienced in a typical episode of care. In the previous payment methods, it is simple to charge for certain fees as it is just a matter of submitting a number where the payment exceeds the costs so a profit can be obtained. In traditional existing payment methods, charges are effectively agreed to base upon existing Medicare and Medicaid Payments or in the case of Private Insurers contractual terms negotiated between insurers and the physician, hospital provider or system and calculated through the coding schemes that apply to the different providers. DRG groupers and other software applications attempt to maximize those charges, but those are based on small changes with the system rather than changes in physician care to reduce costs. This is not the case with the bundled payment models. The interactions among hospital, primary physician, and all the physician specialists are more complex. They must discuss new styles of practice and where patient care costs may be reduced without jeopardizing patient outcomes. Furthermore, payment is somewhat based on outcome which is not the case at all in a FFS model. The combined interrelatedness and matrix interactions require a much more complex analysis in order to decide if the hospital is making money or losing money for a particular disease/diagnosis. This is the precise environment where decision tree analysis modeling is essential. The probabilities of specific outcomes were obtained from the literature. Decision tree modeling takes into account the assorted itemized costs associated with a readmission, which is especially important in a bundled payment model, as readmissions in 90 days will not be paid additional revenues. Even without different therapeutic arms or different measurements of quality adjusted light years (as in a cost effectiveness analysis), this analysis can give much insight into what costs to look at while operating a sepsis case. Sensitivity analysis of the model provides insight into how a hospital can identify specific cost centers for management or process changes to affect costs and improve margins within the framework of a bundled payment. We were able to show that affecting the costs of the ICU stay had the most impact on overall costs whereas changing the payments to the physicians registered minimal changes to costs at all. This type of analysis can therefore direct the administrators to concentrate on affecting costs to the particular areas that have the most financial impact. There are however some limitations to this analysis. Firstly, many cases of sepsis can deteriorate from, for example, SIRS to sepsis with complications, or even to septic shock. This is difficult to model and was one thing we did not incorporate. Perhaps one can add the number of cases converted from SIRS to sepsis with complications, and call that the final probability of sepsis with complications. Notable that the complication rate would likely be minimized as practicable and not primarily related to financial compensation as the reputation of the hospital and its physicians in treating sepsis is logically the most important driver. The numbers used in the analysis are examples, and in practice one must use numbers generated from the local hospital to make up for geographical differences and differences in the success of how patients with sepsis are treated in a particular hospital. So even though the numbers presented in this paper are examples, in practice one can use the actual local numbers to help in making a decision about whether or not a hospital wants to participate in BPCI advanced (currently voluntary). Sepsis, defined as infection with associated organ failure, was identified during the ICU stay in 2973 (29.5%) patients, including in 1808 (18.0%) already at ICU admission as of 2006.[ Occurrence rates of sepsis varied from 13.6% to 39.3% in the different regions. Patients with sepsis accounted for 45% of ICU bed days and 33% of hospital bed days. The ICU length of stay (LOS) was between 4 and 8 days and the median hospital LOS was 18 days.[ If a hospital has 25 ICU beds, which accounts for 9125 ICU bed days, then at a savings of $3873 per admission based on cost containment in the ICU, a hospital would wind up with an additional $2,649,132 in profit if done correctly. (Table 3)

Appendix-example

To demonstrate how the model works, a 60-year-old woman, who is diabetic, comes to the emergency room. She complains of exhaustion and has difficulty breathing. On presentation, she is hypotensive (systolic blood pressure of 70), and also is in acute renal failure (BUN 80, Cr 5.7). Her respirations are labored and as a result, she is intubated. Her urine shows many bacteria and TNTC WBC. Her blood sugar is 480. She is immediately started on fluid resuscitation (normal saline 1-L bolus followed by 120 cm3/h), and then she is started on a neosynephrine drip to maintain her blood pressure. After blood and urine cultures are obtained, she is given IV Rocephin and IV Imipenem antibiotics. She is also started on an insulin drip.[ The patient is transferred to the ICU, where she remains for 5 days. During this time she has to acute hemodialysis 4 times, and it takes 3 days to reduce the neosynephrine so that she maintains a systolic BP of 95 on her own. By the 5th day, the pulmonologist was able to remove her from the ventilator and she was extubated. After urine and blood cultures came back positive for a resistive form of Escherichia coli, she is maintained on the IV Imipenem to which it was sensitive. The patient spends the next 6 days in a ward bed. She continues on IV antibiotics and IV fluids until discharge, but her renal function improved (BUN 32, Cr. 1.2) so that she does not need hemodialysis any longer. Her breathing is adequate and she oxygenated well. Her blood sugars are controlled with oral agents and subcutaneous insulin. She was discharged home in good condition. Now unlike the decision tree, in this example the probability of certain things happening is one (and the other branches 0) so the costs are just summed. The costs for this stay: In the model, there is a probability that each branch will occur. We multiply the probability of each occurrence (here the probability of septic shock is 14%) times the cost, so in the overall analysis this example would contribute (0.14 × $31,688) or $4436 towards the overall costs. When one does this with the costs of the different scenarios and sums the EVs, the calculated cost is $30,386, which is reported in the results section.

Author contributions

Conceptualization: William Matzner, Deborah Freund. Data curation: William Matzner. Formal analysis: William Matzner, Deborah Freund. Methodology: Deborah Freund, William Matzner. Writing – original draft: William Matzner. Writing – review & editing: Deborah Freund.
ICU11,500
...Floor stay6000
Dialysis680
Ventilator2610
Pressor885
Nephro3295
Pulmon3295
Intensivist1192
Primary Care2231
Total31,688
  11 in total

1.  Association of Hospital Participation in a Medicare Bundled Payment Program With Volume and Case Mix of Lower Extremity Joint Replacement Episodes.

Authors:  Amol S Navathe; Joshua M Liao; Sarah E Dykstra; Erkuan Wang; Zoe M Lyon; Yash Shah; Joseph Martinez; Dylan S Small; Rachel M Werner; Claire Dinh; Xinshuo Ma; Ezekiel J Emanuel
Journal:  JAMA       Date:  2018-09-04       Impact factor: 56.272

Review 2.  Update of Sepsis in the Intensive Care Unit.

Authors:  Kelly Roveran Genga; James A Russell
Journal:  J Innate Immun       Date:  2017-07-12       Impact factor: 7.349

3.  The Impact Of Bundled Payment On Health Care Spending, Utilization, And Quality: A Systematic Review.

Authors:  Rajender Agarwal; Joshua M Liao; Ashutosh Gupta; Amol S Navathe
Journal:  Health Aff (Millwood)       Date:  2020-01       Impact factor: 6.301

4.  Cost analysis of dialysis treatments for end-stage renal disease (ESRD).

Authors:  R Goeree; J Manalich; P Grootendorst; M L Beecroft; D N Churchill
Journal:  Clin Invest Med       Date:  1995-12       Impact factor: 0.825

5.  Will Bundled Payments Change Health Care? Examining the Evidence Thus Far in Cardiovascular Care.

Authors:  Terry Shih; Lena M Chen; Brahmajee K Nallamothu
Journal:  Circulation       Date:  2015-06-16       Impact factor: 29.690

6.  Daily cost of an intensive care unit day: the contribution of mechanical ventilation.

Authors:  Joseph F Dasta; Trent P McLaughlin; Samir H Mody; Catherine Tak Piech
Journal:  Crit Care Med       Date:  2005-06       Impact factor: 7.598

7.  Unplanned Readmissions After Hospitalization for Severe Sepsis at Academic Medical Center-Affiliated Hospitals.

Authors:  John P Donnelly; Samuel F Hohmann; Henry E Wang
Journal:  Crit Care Med       Date:  2015-09       Impact factor: 7.598

8.  Two-Year Evaluation of Mandatory Bundled Payments for Joint Replacement.

Authors:  Michael L Barnett; Andrew Wilcock; J Michael McWilliams; Arnold M Epstein; Karen E Joynt Maddox; E John Orav; David C Grabowski; Ateev Mehrotra
Journal:  N Engl J Med       Date:  2019-01-02       Impact factor: 91.245

9.  Sepsis-Associated 30-Day Risk-Standardized Readmissions: Analysis of a Nationwide Medicare Sample.

Authors:  Brett C Norman; Colin R Cooke; E Wes Ely; John A Graves
Journal:  Crit Care Med       Date:  2017-07       Impact factor: 7.598

10.  Epidemiology of sepsis in intensive care units in Turkey: a multicenter, point-prevalence study.

Authors:  Nur Baykara; Halis Akalın; Mustafa Kemal Arslantaş; Volkan Hancı; Çiğdem Çağlayan; Ferda Kahveci; Kubilay Demirağ; Canan Baydemir; Necmettin Ünal
Journal:  Crit Care       Date:  2018-04-16       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.